NantWorks
NantWorks LLC founded in 2007[1] with headquarters in Culver City, California[2] is an American multinational conglomerate holding company. It owns a number of technology companies in the fields of healthcare, commerce, digital entertainment as well as a venture capital firm in the healthcare, education, science, and technology sectors. Particular technologies include machine vision, object and voice recognition, low power semiconductors, supercomputing, and networking technologies.[3]
The Chairman, CEO and founder of NantWorks is American physician Patrick Soon-Shiong.[1]
| Type | Public |
|---|---|
| Industry | Conglomerate |
| Founded | 2007 |
| Headquarters | , |
Key people | Patrick Soon-Shiong (founder) |
| Products |
|
| Subsidiaries |
|
| Website | nantworks |
The constituent companies of the NantWorks Group are:
- NantHealth
- NantCloud (est. 2010, acquired by NantHealth in 2015, healthcare cloud computing[4]).
- NantOmics
- NantBioScience
- NantCell
- NantKwest Inc. (immunotherapy for treatment of cancers, infectious, and inflammatory diseases[5][6][7])
- NantPharma (also: Nant Pharma) LLC (est. 2012 with investments from Blackstone,[8] manufactures and markets crude heparin, biologically derived pharmaceuticals including critical care injectable and oncological drugs.,[9][10] exclusive license agreement with AmGen[11])
- NantMobile (mobile marketing[12][13])
- NantStudio (Soundstage for traditional and virtual production [14][15])
- NantCapital (also: Nant Capital) LLC (est. 2012, investment and venture capital,[16][17] owner of Los Angeles Times and San Diego Union Tribune [18]) and
- ImmunityBio[19]
References
- Lawrence, Stacy (2015-05-13). "Dr. Patrick Soon-Shiong - NantWorks". FierceBiotech. Retrieved 2019-07-09.
- https://www.crunchbase.com/organization/nantworks#section-overview
- https://www.bloomberg.com/profile/company/0203805D:US
- https://www.crunchbase.com/organization/nantcloud
- https://nantkwest.com/
- https://finance.yahoo.com/quote/nk?ltr=1
- https://www.bloomberg.com/quote/NK:US
- https://www.blackstone.com/media/press-releases/article/blackstone-invests-$125-million-in-nantpharma-a-nantworks-company-
- https://www.bloomberg.com/profile/company/0566816D:US
- https://www.nantpharma.com/
- https://www.businesswire.com/news/home/20150914005375/en/NantWorks-Enters-Exclusive-License-Agreement-Amgen-Target
- https://www.crunchbase.com/organization/nantmobile
- https://nantmobile.com/
- https://www.crunchbase.com/organization/nantstudio
- https://nantstudio.com
- https://www.bloomberg.com/profile/company/1404960D:US
- https://www.crunchbase.com/organization/nantcapital
- "Nant Capital LLC buys Los Angeles Times from tronc inc". Orange County Breeze. 2018-07-24. Retrieved 2019-07-09.
- "NantKwest and ImmunityBio Announce Therapeutics and Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Quarter". BioSpace.com. 14 April 2020.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.